Water Island Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Water Island Capital’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-722,234	Closed	-$2.2M	–	105
2024 Q4	$2.2M	Sell	722,234 -1,658,962	-70%	-$7.23M	0.24%	55
2024 Q3	$12.4M	Buy	+2,381,196	New	+$11.8M	1.24%	25

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Water Island Capital's RVNC Position: Q1 2025 in Review

Water Island Capital sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 722,234 shares — an estimated $2.2M sold.

Water Island Capital first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $12.4M in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

Water Island Capital reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
Water Island Capital sold 722,234 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $2.2M.
Water Island Capital first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
Water Island Capital's Revance Therapeutics, Inc. position peaked at $12.4M in Q3 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Water Island Capital's 13F filing for Q1 2025, filed 15 May 2025.